Current HIV Research

Author(s): Mehmet Cabalak*, Oya Soylu Karapınar and Cigdem El

DOI: 10.2174/011570162X349194241125052104

DownloadDownload PDF Flyer Cite As
Assessment of Pregnancy Status in Patients with Acquired Immunodeficiency Syndrome and their Partners

Page: [402 - 408] Pages: 7

  • * (Excluding Mailing and Handling)

Abstract

Background: HIV is a globally prevalent infection for which there is currently no cure or vaccine. As the number of individuals with HIV infection increases, so does the number of individuals wishing to have children despite being infected. This situation has highlighted issues related to couples where one partner is infected while the other is not (serodiscordant couples) and couples where both partners are positive. Major issues include pregnancy complications, transmission to the child, and potential side effects of the ART treatment on the health of the child. Women living with HIV who become pregnant or contract the virus during pregnancy are at risk for both maternal and perinatal morbidity and mortality, especially if the virus is not adequately controlled. Additionally, there is a risk of vertical transmission through breastfeeding during pregnancy and postpartum. To mitigate the consequences of HIV during pregnancy, it is ideal to start with prepregnancy counseling and plan pregnancies during periods of minimal viral load using appropriate methods.

Aims and Objective: There are limited studies and shared experiences regarding fertility status and issues of HIV/AIDS patients, especially in Turkey. Hence, this study aimed to investigate the fertility status of HIV/AIDS patients and their partners followed up in our clinic, shed light on the encountered issues, and share our experiences.

Methods: This retrospective, observational, single-center cross-sectional study included HIV/AIDS patients and their partners followed at Hatay Mustafa Kemal University (MKÜ) Medical Faculty Hospital from January 2018 to December 2023. Demographic data of the patients, their sexual orientations, HIV/AIDS status of their partners and children, treatments received, CD4 cell counts, and viral load data were retrospectively obtained from the automation system of our hospital and patient files.

Results: Among the couples, there were 21 pairs where both partners were HIV positive, 10 pairs where the woman was HIV positive and the man was seronegative (serodiscordant), and 5 pairs where the man was HIV positive and the woman was seronegative. In our study, eight couples with both partners HIV positive had nine children, and six couples with women who were HIV positive (serodiscordant) had ten children. The five couples with men who were HIV positive (serodiscordant) had six children. No vertical transmission was observed in our study, but three patients did not attend regular follow-ups. During the follow-up period, no seroconversion was detected in the partners of serodiscordant patients. The average gestational age was 38 weeks, and the average birth weight was 2873 ± 349 grams.

Conclusion: Our study found no vertical transmission and no seroconversion in partners of serodiscordant couples. Issues related to pregnancy in HIV-positive couples can be managed with pre-pregnancy counseling by specialists, protective methods, appropriate ART, and perinatal follow- up.

Keywords: HIV, pregnancy, serodiscordant couples, vertical transmission, antiretroviral therapy, cesarean section.

[2]
Ministry General Directorate of Public Health. Department of Infectious Diseases and Early Warning, documents, HIV-AIDS statistics. Available from: https://hsgm.saglik.gov.tr/tr/dokumanlar-bulasicihastaliklar
[3]
Chilaka VN, Konje JC. HIV in pregnancy – An update. Eur J Obstet Gynecol Reprod Biol 2021; 256: 484-91.
[http://dx.doi.org/10.1016/j.ejogrb.2020.11.034] [PMID: 33246666]
[4]
Sonnenberg-Schwann U, Weigel M. HIV andwanting to be a parent. In: Hoffmann C, Rockstroh JK, Eds. HIV 2015/2016. Hamburg, Germany: Medicine Focus Publishing 2012/2013; pp. 547-72.
[5]
Guidance on couples HIV testing and counselling including antiretroviral therapy for treatment and prevention in serodiscordant couples: Recommendations for a public health approach. 2012. Available from: https://iris.who.int/handle/10665/44646
[6]
Del Romero J, Castilla J, Hernando V, Rodríguez C, García S. Combined antiretroviral treatment and heterosexual transmission of HIV-1: Cross sectional and prospective cohort study. BMJ 2010; 340(may14 1): c2205.
[http://dx.doi.org/10.1136/bmj.c2205] [PMID: 20472675]
[7]
Mandelbrot L, Tubiana R, Le Chenadec J, et al. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception. Clin Infect Dis 2015; 61(11): civ578.
[http://dx.doi.org/10.1093/cid/civ578] [PMID: 26197844]
[8]
Choudhury B, Stadnyk M, Jijon DF, et al. Pregnancy among HIV-serodiscordant couples: Case report of vertical transmission and retrospective case series. Curr HIV Res 2021; 19(3): 269-76.
[http://dx.doi.org/10.2174/1570162X18999201231211658] [PMID: 33390144]
[9]
Wei HH, Tsai LP, Wu PS. Adolescent onset of vertically transmitted untreated AIDS: A report of one case. Tzu-Chi Med J 2016; 28(4): 173-5.
[http://dx.doi.org/10.1016/j.tcmj.2015.12.002] [PMID: 28757752]
[10]
Guthrie BL, Choi RY, Bosire R, et al. Predicting pregnancy in HIV-1-discordant couples. AIDS Behav 2010; 14(5): 1066-71.
[http://dx.doi.org/10.1007/s10461-010-9716-x] [PMID: 20544384]
[11]
Gemmill A, Bradley SEK, van der Poel S. Reduced fecundity in HIV-positive women. Hum Reprod 2018; 33(6): 1158-66.
[http://dx.doi.org/10.1093/humrep/dey065] [PMID: 29579247]
[12]
Nakiganda LJ, Agardh A, Asamoah BO. Cross-sectional study on the prevalence and predictors of pregnancy among women living in HIV discordant relationships in a rural Rakai cohort, Uganda. BMJ Open 2018; 8(4): e019818.
[http://dx.doi.org/10.1136/bmjopen-2017-019818] [PMID: 29691244]
[13]
Savasi V, Mandia L, Laoreti A, Cetin I. Reproductive assistance in HIV serodiscordant couples. Hum Reprod Update 2013; 19(2): 136-50.
[http://dx.doi.org/10.1093/humupd/dms046] [PMID: 23146867]
[14]
Zafer M, Horvath H, Mmeje O, et al. Effectiveness of semen washing to prevent human immunodeficiency virus (HIV) transmission and assist pregnancy in HIV-discordant couples: A systematic review and meta-analysis. Fertil Steril 2016; 105(3): 645-655.e2.
[http://dx.doi.org/10.1016/j.fertnstert.2015.11.028] [PMID: 26688556]
[15]
Zorrilla C, Reyes-Báez F, González-Colón K, Ibarra J, García-Acevedo I, Mosquera A. HIV seroconversion during pregnancy and the need for pre-exposure prophylaxis (PrEP). HIV AIDS (Auckl) 2018; 10: 57-61.
[http://dx.doi.org/10.2147/HIV.S140799] [PMID: 30804684]
[16]
Inkaya AÇ, Örgül G, Halis N, et al. Perinatal outcomes of twenty- five human immunodeficiency virus-infected pregnant women: Hacettepe University experience. J Turk Ger Gynecol Assoc 2020; 21(3): 180-6.
[http://dx.doi.org/10.4274/jtgga.galenos.2019.2019.0033] [PMID: 31564083]
[17]
Sütçü M, Aktürk H, Somer A, et al. Mother-to-child transmisson of HIV: An eight-year experience. Mikrobiyoloji Bulteni 2015; 49(4): 542-53.
[http://dx.doi.org/10.5578/mb.9838] [PMID: 26649412]
[18]
Yakut N, Kepenekli E. Evaluation of infants with HIV infected mothers and perinatal transmission in Turkey: A single-center experience. North Clin Istanb 2021; 8(3): 243-8.
[http://dx.doi.org/10.14744/nci.2021.59013] [PMID: 34222804]
[19]
Zerdali E, Mete B, Altuntaş Aydın Ö, et al. Factors influencing HIV infection in children born to HIV-infected mothers in Turkey. Balkan Med J 2023; 40(5): 367-72.
[http://dx.doi.org/10.4274/balkanmedj.galenos.2023.2023-3-12] [PMID: 37350727]